Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Ovarian Cancer treatment details. Hormone. Christie Hospital, Manchester, United Kingdom

Survival: 13.6 months
Toxicity Grade: 2
Treatments: Hormone
Drugs: Nolvadex
Country: United Kingdom
City/State/Province: Manchester
Hospital: Christie Hospital
Journal: Link
Date: 9/2005

Patients: This phase I/II study involved a total of 26 women with recurrent epithelial ovarian cancer. The median age was 63.

Treatment: The treatment consisted of two hormone therapy agents - tamoxifen and goserelin (Zoladex).

Toxicity: No grade 3/4 toxicities were reported. Grade 2 toxicities included hot flushes.

Results: Median survival was 13.6 months.

Support: The study was "supported by a generous grant from Astra-Zeneca." Astra-Zeneca manufactures or markets tamoxifen and zoladex.

Correspondence: J. Hasan, MD

E-mail to a Friend Email Physician More Information